PedAM
Pediatric Disease Annotations & Medicines
| Disease | schizophrenia |
| Symptom | C0917801|insomnia |
| Sentences | 9 |
| PubMedID- 26356092 | This study examines cognitive and behavioral factors linked to insomnia in individuals with schizophrenia and other psychotic disorders (with and without insomnia) and healthy controls (with and without insomnia). |
| PubMedID- 21367359 | In insomnia linked with schizophrenia, treatment often involves antipsychotics and sedative hypnotics which are only partially effective in the long term, and are often associated with a daytime “hangover” effect, which can contribute to poor global functioning (kantrowitz, citrome, & javitt, 2009). |
| PubMedID- 20435247 | Commenting on"a review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia," by kantrowitzet al. |
| PubMedID- 24083027 | The disadvantages of drug treatment for insomnia in patients with schizophrenia underline the importance of seeking alternative nonpharmacological treatments, among them complementary medicine techniques such as shiatsu, reflexology, and acupuncture. |
| PubMedID- 23845104 | The implication is that treating insomnia in patients with schizophrenia will lessen psychotic symptoms. |
| PubMedID- 21057240 | Diazepam discontinuation through agomelatine in schizophrenia with insomnia and depression. |
| PubMedID- 19939868 | insomnia associated with chronic schizophrenia and after clozapine discontinuation represents a common, but mostly not predominant, complaint and often does not respond sufficiently to classical hypnotics. |
| PubMedID- 21975110 | However, in general practice settings two randomized, placebo-controlled trials with respectively 34 and 38 participants (with insomnia not associated with schizophrenia) reported contradictory results . |
| PubMedID- 21983496 | Randomized, controlled clinical trials examining adjunctive use of antidepressants, anxiolytics and sedative/hypnotics to target symptoms of anxiety, depression, and insomnia in patients with schizophrenia are needed to adequately address the efficacy of these interventions. |
Page: 1